19 results
10-K
2023 FY
MIRA
Mira Pharmaceuticals Inc
1 Apr 24
Annual report
7:00am
and clinical trials, and our research and development programs;
the timing of anticipated regulatory filings;
the timing of availability of data from … for technology in our research and development programs, where applicable, and their uses by filing patent applications in the United States
8-K
MIRA
Mira Pharmaceuticals Inc
13 Mar 24
Departure of Directors or Certain Officers
4:30pm
Executive Officer of stem-cell company Accellta (Haifa, Israel) and Vice President for Research and Development at Proteologics Ltd, and at D-Pharm
10-Q
cd2ep6l6xcn7po y7w
15 Sep 23
Quarterly report
4:45pm
424B4
1nl7 fh3cg
4 Aug 23
Prospectus supplement with pricing info
1:01pm
424B1
cea0fv
4 Aug 23
Prospectus with pricing info
12:59pm
S-1
9b78vsp4mmse pmhyj4
29 Jun 23
IPO registration
4:39pm
S-1
EX-10.5
ttt57oonwx7nkm5vrn97
29 Jun 23
IPO registration
4:39pm
DRS/A
EX-10.5
31ga9913w8c97z4 gl
8 Jun 23
Draft registration statement (amended)
12:00am
DRSLTR
92yzrfuccd4vf0ef d25
8 Jun 23
Correspondence regarding draft registration statement
12:00am
DRS/A
83750cm
8 Jun 23
Draft registration statement (amended)
12:00am
UPLOAD
acg7un1otv237l5
30 May 23
Letter from SEC
12:00am
DRS/A
lo8l fuyt
2 May 23
Draft registration statement (amended)
12:00am
DRS
r96z6pvf5d0kj
29 Jun 22
Draft registration statement
12:00am
- Prev
- 1
- Next